Bronchiectasis Alternative Therapy

Individuals With Bronchiectasis May Benefit From an Alternative Therapy – Stem Cell Treatment

Stem cell therapy is a breakthrough alternative for many individuals with bronchiectasis. This innovative treatment is available at the Lung Institute, the only stem cell therapy center in the world that focuses exclusively on treating chronic obstructive lung conditions. While autologous stem cell therapy is not curative, it can potentially halt the progression of bronchiectasis, improve lung function and enhance quality of life.

Stem cells stand out among the billions of other cells that make up the human body. Most of these cells are lineage-committed, which means that they are specialized to perform a specific function. Stem cells, on the other hand, are highly unique in that they are undifferentiated. Not only are they capable of perpetuating themselves through a process known as self-renewal, but they also can transform themselves into other types of cells. This means that stem cells can potentially serve as a healing mechanism and replicate healthy lung tissue that has been lost through damage, such as the scarring that occurs as a result of bronchiectasis.

At the Lung Institute, we offer blood- and bone-marrow-based stem cell therapy as an alternative treatment for bronchiectasis. In accordance with our treatment guidelines, these minimally invasive procedures are performed on an outpatient basis over the course of two days. In general, stem cell therapy involves three main steps:

  • Harvesting stem cells from a patient’s blood or bone marrow
  • Isolating the stem cells in our in-house lab
  • Reintroducing the concentrated stem cells into the patient’s bloodstream via intravenous infusions

The Lung Institute upholds the highest level of medical standards and quality with a full compliance team overseeing all operations. Our clean, bright and modern facilities are staffed by a dedicated team of compassionate professionals who work hard to ensure an exceptional, concierge-like patient experience.

If you’d like to learn more about stem cell therapy as an alternative treatment for bronchiectasis, contact the Lung Institute at (800) 729-3065 to discuss your options.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.